RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of VRPX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in Virpax Pharmaceuticals, Inc. stock price on Thursday moving 14.55% between high and low
(Updated on Mar 28, 2024)

Buy or Hold candidate since Mar 07, 2024 Gain 0.74% PDF

The Virpax Pharmaceuticals, Inc. stock price gained 13.03% on the last trading day (Thursday, 28th Mar 2024), rising from $3.77 to $4.26. During the last trading day the stock fluctuated 14.55% from a day low at $3.72 to a day high of $4.26. The price has been going up and down for this period, and there has been a 10.11% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 8 thousand more shares were traded than the day before. In total, 15 thousand shares were bought and sold for approximately $65.62 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 416.25% during the next 3 months and, with a 90% probability hold a price between $9.73 and $30.86 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

VRPX Signals & Forecast

The Virpax Pharmaceuticals, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $4.04 and $2.46. A breakdown below any of these levels will issue sell signals. Virpax Pharmaceuticals, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, March 11, 2024, and so far it has fallen -13.92%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Virpax Pharmaceuticals, Inc. stock

Virpax Pharmaceuticals, Inc. finds support from accumulated volume at $4.18 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.541 between high and low, or 14.55%. For the last week, the stock has had daily average volatility of 11.04%.

Our recommended stop-loss: $4.01 (-6.01%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 13 days ago.)

Trading Expectations (VRPX) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Virpax Pharmaceuticals, Inc. to open at $4.08, and during the day (based on 14 day Average True Range), to move between $3.77 and $4.75, which gives a possible trading interval of +/-$0.494 (+/-11.59%) up or down from last closing price. If Virpax Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 23.17% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.18 (2.02%) than the resistance at $4.39 (2.93%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Virpax Pharmaceuticals, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Virpax Pharmaceuticals, Inc. stock to perform well in the short-term.

Current score: 3.772 Buy Candidate Unchanged

Predicted Opening Price for Virpax Pharmaceuticals, Inc. of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$4.08 ( 4.23%) $4.26

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for VRPX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.62 8.47 %
R2 4.42 3.62 %
R1 4.29 0.618 %
Current price: 4.26
Support S1 3.87 -9.09 %
S2 3.75 -12.08 %
S3 3.54 -16.93 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.95 16.16 %
R2 4.53 6.31 %
R1 4.39 2.93 %
Current price 4.26
Support S1 4.18 -2.02%
S2 4.02 -5.66%
S3 3.51 -17.63%

FAQ

What is the symbol for Virpax Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Virpax Pharmaceuticals, Inc. is VRPX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Virpax Pharmaceuticals, Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Virpax Pharmaceuticals, Inc. stock to perform well in the short-term.

How to buy Virpax Pharmaceuticals, Inc. Stock?
Virpax Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Virpax Pharmaceuticals, Inc. Stock.

What's the current price of Virpax Pharmaceuticals, Inc. Stock?
As of the end of day on the 2024-03-28, the price of an Virpax Pharmaceuticals, Inc. (VRPX) share was $4.26.

What is the 52-week high and low for Virpax Pharmaceuticals, Inc. Stock?
The 52-week high for Virpax Pharmaceuticals, Inc. Stock is $5.48 and the 52-week low is $0.240.

What is the market capitalization of Virpax Pharmaceuticals, Inc. Stock?
As of the 2024-03-28, the market capitalization of Virpax Pharmaceuticals, Inc. is 4.992M.

When is the next earnings date for Virpax Pharmaceuticals, Inc.?
The upcoming earnings date for Virpax Pharmaceuticals, Inc. is May 10, 2024.
Click to get the best stock tips daily for free!

About Virpax Pharmaceuticals, Inc.

Virpax Pharmaceuticals. Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical nonsteroidal anti-inflammatory drug treatment for chronic osteoarthritis of the knee; Probudur, an inject... VRPX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT